Search for Clinical Trial Results

Sponsored By

Aspergillosis, Allergic Bronchopulmonary - 14 Studies Found

Status Study
Active, not recruiting Study Name: Protocol TARC-ABPA
Condition: Allergic Broncho-Pulmonary Aspergillosis
Date: 2012-10-15
Interventions: Other: Study of predictive factors Phase 1 : Inclusion of
Completed Study Name: Trial on the Efficacy and Safety of Two Different Glucocorticoid Dose Regimens in Allergic Bronchopulmonary Aspergillosis
Condition: Allergic Bronchopulmonary Aspergillosis
Date: 2009-09-09
Interventions:
  • Drug: Glucocorticoids Predniso
Completed Study Name: Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary Aspergillosis
Condition: Allergic Bronchopulmonary Aspergillosis
Date: 2012-06-12
Interventions:
  • Drug: Prednisolone Prednisolon
Not yet recruiting Study Name: A Study Evaluating Vitamin D in Allergic Bronchopulmonary Aspergillosis Complicating Asthma
Condition: Allergic Bronchopulmonary Aspergilloses
Date: 2017-04-21
Interventions:
  • Drug: Glucocorticoids Oral pre
Recruiting Study Name: A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis
Condition: Allergic Bronchopulmonary Aspergillosis
Date: 2015-05-01
Interventions:
  • Drug: Itraconazole Oral itraco
Completed Study Name: Monotherapy of Itraconazole Versus Prednisolone in Allergic Bronchopulmonary Aspergillosis
Condition: Allergic Bronchopulmonary Aspergillosis
Date: 2011-03-23
Interventions:
  • Drug: Glucocorticoids Predniso
Completed Study Name: A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary Aspergillosis
Condition: Allergic Bronchopulmonary Aspergillosis
Date: 2013-05-13
Interventions:
  • Drug: Inhaled budesonide The c
Completed Study Name: Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis
Condition:
  • Cystic Fibrosis
  • Allergic Bronchopulmonary Aspergillosis
    • Date: 2010-10-14
    Interventions: Dietary Supplement: cholecalciferol (Vitamin D3) 4,000 IU of cholecalciferol (Vitamin D3) orally every d
Completed Study Name: Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA
Condition:
  • Cystic Fibrosis
  • Allergic Bronchopulmonary Aspergillosis
    • Date: 2008-01-01
Recruiting Study Name: Lung MRI and Allergic Broncho-pulmonary Aspergillosis in Cystic Fibrosis
Condition:
  • Pulmonary Cystic Fibrosis
  • ABPA

Date: 2016-07-26
Next >>>